Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Actinium Pharmaceuticals, Inc.

NYSE: ATNM · Life Sciences · 1 alert · CIK 1388320

Share price
$1.49Close, Nov 16
Market cap
$46.8M
Shares outstanding
31.44MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Actinium Pharmaceuticals, Inc. filings on SEC EDGAR ↗

5:05 PM ET 8-K
Executive Compensation

Actinium Pharmaceuticals Executive Compensation

Actinium Pharmaceuticals appointed Matt David, M.D., as Chief Financial Officer, effective October 14, 2026. Dr. David's compensation package includes a $450,000 base salary, a $150,000 sign-on bonus, and an inducement grant of 250,000 stock options and 325,000 restricted stock units.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.